Replay available

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call

Evolent Health, Inc. (NYSE: EVH) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Thu, May 7, 2026 at 8:00 AMendedReplay
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Seth Blackley

Chief Executive Officer

Mario Ramos

Chief Financial Officer

John Stancil

Analyst, J.P. Morgan

Jared Haas

Analyst, William Blair

Kevin Caliendo

Analyst, UBS

Jessica Tawson

Analyst, Piper Sandler

David Larson

Analyst, BCIG

Unidentified Speaker

Replay transcript excerpt

Welcome to the Evelyn Earnings Conference Call for the first quarter ended March 31, 2026. As a reminder, this conference call is being recorded. Your hosts for the call today from Evelyn are Seth Blackley, Chief Executive Officer, and Mario Ramos, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company's website in the section titled Investor Relations. This conference call will contain forward-looking statements under the U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our third quarter press release issued earlier today. Finally, as a reminder, Reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation available in the Investor Relations section of our website or in the company's press release issued today and posted on the Investor Relations website, ir.evalent.com, and the Form 8-K filed by the company with the SEC earlier today. In addition to reconciliations, We provide details on the numbers and operating metrics for the quarter in both our press release and supplemental investor presentation. And now, I will turn the call over to Evelyn's CEO, Seth Blackley. Please go ahead. Good morning, and thank you for joining us. Today, Evelyn reported strong firs...

More from Evolent Health, Inc